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A B S T R A C T
A long-term study was undertaken to monitor immune responses, faecal cultures and clinical disease in
sheep experimentally infected with Mycobacterium avium subspecies paratuberculosis (Map) strain
Telford. New Zealand Merino lambs (N = 56) were challenged with three oral doses of Map suspension.
The lambs were weighed and faecal and blood samples obtained at different time-points. At 63 weeks
post-challenge, surviving sheep were euthanised and samples of liver, ileo-caecal valve and mesenteric
lymph node were collected for histopathology and Map culture. High IFN-g and antibody responses were
evident as early as 8 weeks post-C1 which persisted until the end of the trial. Approximately 92% of the
sheep shed Map in faeces at 36 weeks post-challenge, with the prevalence decreasing to around 40% at
the end of the trial. Thirteen sheep progressively lost weight and were euthanised between weeks 32 and
58 post-challenge. Nearly 58% of surviving sheep exhibited histo-pathological lesions in at least one of
the three tissues sampled, while 42% showed acid-fast bacilli in at least one tissue. A positive Map culture
in at least one tissue was obtained from approximately 85% of sheep. These results indicate that the three
doses of Map challenge were highly effective in establishing Johne’s disease in NZ Merino lambs.
ã 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Johne’s disease (JD) or paratuberculosis is a chronic intestinal
infection of ruminants caused by Mycobacterium avium subspecies
paratuberculosis (Map). Several experimental sheep infection
studies (reviewed by Hines et al., 2007; Begg and Whittington,
2008) have been conducted to determine the pathogenesis and
immunological aspects of JD and to evaluate protective efﬁcacy of
vaccines. These studies are frequently difﬁcult to reproduce
because the infectious material is derived from either intestinal
mucosal extracts or ad hoc laboratory-adapted cultures of Map that* Corresponding author.
E-mail address: R.Dukkipati@massey.ac.nz (V.S.R. Dukkipati).
http://dx.doi.org/10.1016/j.vetmic.2016.09.018
0378-1135/ã 2016 The Authors. Published by Elsevier B.V. This is an open access article unare not clearly deﬁned. An experimental model for JD in sheep was
developed in Australia (Begg et al., 2010), based on a lyophilised,
low passage (level 5), pure culture, seed-stock of Map strain,
Telford 9.2, isolated from a clinical ovine case. A series of
experiments conducted in that study showed authentic experi-
mental reproduction of the natural features of JD in sheep that
were less than 2 years of age. The range of histopathological lesions
observed ranged from very mild focal lesions to extensive
granulomatous inﬂammation as might be found following natural
infection. Faecal shedding was intermittent with 61% of animals
classiﬁed as infected at necropsy being culture positive at least
once. Immunological assays showed that interferon gamma (IFN-
g) assays detected animals in the earlier stages of infection
whereas antibody ELISA detected animals more often as the
infection progressed. All these features plus the fact that theder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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consistent with the spectrum of infection and disease that could be
expected in sheep that have been naturally infected.
The primary objective of this long-term study was to investigate
the kinetics of immune responses and faecal shedding of Map, as
well as the incidence of clinical disease in New Zealand Merinos
infected with three doses of cultured Map strain Telford 9.2. The
trial was performed at Massey University in the Manawatu region
of North Island, New Zealand using Merino wether lambs. Three
doses of Map organisms were administered over a four week period
and immune responses and animal weights were monitored at
regular intervals and faecal samples collected for Map culture.
Antibody responses and puriﬁed protein derivative of Mycobacte-
rium avium (PPDA) induced IFN-g responses were measured at
regular intervals and the trial terminated after 63 weeks post-
infection. Surviving animals were necropsied and tissue samples
collected for histopathology and Map tissue culture.
2. Materials and methods
2.1. Experimental animals, Map challenge and sampling
Fifty six purebred New Zealand (NZ) Merino wether lambs were
procured from a commercial farm with no previous history of JD
(no unexplained mortalities or progressive weight loss in adult
sheep). Serological screening for Map antibodies in 20 randomly
selected ewes in the source farm revealed all the ewes (that were
over 6 years of age when tested) to be negative for JD. Also, all 56
lambs tested negative for Map sensitisation, in a whole blood IFN-g
assay, performed using a Bovigam1 kit. The lambs were managed
under conventional NZ sheep farming conditions in a specially
prepared set of quarantine paddocks and grazed on pasture
throughout the trial.
When the lambs were approximately 4 months of age, they
were challenged orally with three doses of Map suspension (from
cultures seeded with the reconstituted lyophilised stock described
in Begg et al., 2010). The intervals between successive doses were 1
and 3 weeks, respectively (Fig. 1). The lyophilised seed stock wasFig. 1. Illustration of Map challengoriginally prepared from a clonal culture at ﬁnal passage level 5
(including its primary isolation from sheep faeces) of Telford 9.2,
an IS1311S Map strain (IS900 RFLP type S1), isolated from a clinical
ovine case in New South Wales, Australia. Details of culturing from
the seed stock, bacterial enumeration and preparation of inoculum
were as described in Begg et al. (2010). Map suspensions (10X
concentration in phosphate buffered saline, PBS) prepared from
the cultures were shipped overnight at refrigeration temperature
(2–8 C) from Australia, diluted (to 1X concentration) with sterile
PBS and 10 ml was administered per animal through a syringe to
the back of the throat. Viable counts of Map were determined at the
University of Sydney by end point titration in BACTEC medium,
using a three tube most probable number method (Reddacliff et al.,
2003). The viable Map counts in the three challenge (C) doses were
2.1 107 (C1), 9.3  106 (C2) and 2.3  108 (C3).
The lambs were weighed and faecal samples obtained on the
day of C1 and subsequently at monthly intervals. Body weights
recorded at 36 and 41 weeks post-C1 were excluded from analyses
as the sheep body coat at those time-points was wet and thus
inﬂated the weights. Faecal samples were either cultured (for Map)
immediately or stored at 80 C until processed for culturing.
Jugular blood samples (to measure immune responses) were
obtained at 2 weeks prior to C1, as well as at 4, 8, 16, 32, 45, 49, 54,
58 and 62 weeks post-C1. The study protocol was approved by
Massey University Animal Ethics Committee.
2.2. Monitoring post-challenge
Post-challenge, the sheep were monitored daily by a farm
technician. Also, the sheep were inspected by an experienced
sheep veterinarian on at least a fortnightly basis to monitor their
general health and body condition. The sheep were fed pasture
throughout the study and at times when this became scarce,
supplemented with barley. They received an effective anthelmin-
tic treatment at 3–4 weekly intervals. Animals exhibiting >10%
decline in monthly bodyweight and or rapid decline in body
condition were euthanized, and necropsied by a veterinary
pathologist. Tissue samples (liver, ileum and mesenteric lymphe study design and timeline.
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were also performed on all animals that died during the course of
the trial.
2.3. Immune responses
Whole blood IFN-g responses to puriﬁed protein derivative of
Mycobacterium avium (PPDA; 12.5 mg per well) and concanavalin A
(20 mg per well; positive control) and phosphate buffered saline
(PBS; blank) were tested by incubating 0.5 ml heparinised blood in
0.5 ml RPMI 1640 medium (Life Technologies, Carlsbad, CA, United
States of America) containing 5% foetal bovine serum (Life
Technologies) and antibiotic (100 units of penicillin and 100 mg
of streptomycin) and antimycotic (0.25 mg of amphotericin B)
solution (Life Technologies), for 72 h in a humidiﬁed CO2 incubator
at 37 C. Tests were performed in duplicate for each antigen in
sterile 24-well plates. At the end of 72 h incubation, 50 ml of
supernatant was harvested and IFN-g assays done using a
Bovigam1 kit (Prionics AG, Switzerland), as per the manufacturer’s
instructions. IFN-g responses were expressed as PBS corrected
optical density readings at 450 nm (OD450). Antibodies in serum
against Map were detected using a commercial ELISA kit (Para-
tuberculosis screening kit, Institut Pourquirer, France). Serum
samples, incubated with Mycobacterium phlei extract (in order to
remove non-speciﬁc antibodies), were added to antigen coated
wells and immune-assay carried out as per the kit protocol.
Corrected (negative control readings subtracted) antibody
responses, corrected OD450, were expressed as percentage of
corrected positive control readings and individual sheep with %
OD450 readings of >70% were considered positive for Map
antibodies.
2.4. Necropsy and tissue sampling
Surviving sheep at 63 weeks post-C1 were euthanized by the
captive bolt method and then examined for evidence of gross
lesions of JD. Approximately a square cm each of liver, ileo-caecal
valve (ICV) and mesenteric lymph node (MLN) was collected for
histopathological analysis (formalin-ﬁxed), as well as for Map
culture. Tissues for Map culture were frozen at 80 C (for up to 2
months) until processed.Fig. 2. Body weights and average daily gains over time in Merino2.5. Histopathology
Tissues collected at post mortem were ﬁxed in 10% neutral
buffered formalin for at least 24 h prior to routine embedding in
parafﬁn and sectioning at 4 mm. Sections from each tissue (ICV,
MLN and liver) were stained with haematoxylin and eosin (H&E),
as well as Ziehl-Neelsen (ZN) stains. Slides were scored blind by a
veterinary pathologist. Sections of ICV and MLN were subjectively
graded (on a 0–5 scale) based on % inﬁltration (0 = no inﬁltration;
1 = <5%; 2 = 5–20%; 3 = 21–40%; 4 = 41–60%; 5 = >60%) of macro-
phages forming typical mycobacterial granulomas. The liver
sections were graded (on a 0 to 5 scale) based on the number of
granulomas (0 = no granuloma; 1 = <1; 2 = 1; 3 = 2–4; 4 = 5–9; 5 = 10
or more) per ﬁeld, 40 magniﬁcation. All sections with evidence of
typical mycobacterial granulomas were examined for acid-fast
bacilli (AFB) and were subjectively graded (on a scale of 0–5) based
on the number of organisms (0 = no AFB; 1 = single organism;
2 = organisms uncommon; 3 = small number of organisms in some
macrophages; 4 = moderate organisms in lesions; 5 = large number
of organisms present in lesions).
2.6. Map culture and genetic analysis of Map
Faecal samples from individual sheep collected on the day of C1
and those at 36, 41, 45, 49, 54, 58 and 62 weeks post-C1, as well as
tissue samples (liver, ICV and MLN) obtained from individual sheep
necropsied at 63 weeks post-C1 were sent to the AgResearch,
Infectious Diseases Laboratory, Wallaceville Animal Research
Centre, Upper Hutt, for Map culture using the BACTEC system.
Faecal samples (1.5–3 g) were added to a sterile 50 ml centrifuge
tube containing 40 ml of RO water and the suspension was shaken
vigorously for 20 min, allowed to stand for approximately 20 min
so that the heavier particles had time to sediment, and then 5 ml
from the top of the tube was transferred to a new 50 ml tube
containing 35 ml of a solution containing 1% Cetyl pyridinium
chloride (CPC, Sigma) and this suspension was incubated at 35–
37 C for approximately 16–24 h. Cells were pelleted by centrifu-
gation at 3500  g for 20 min at 15 C and the pellet was re-
suspended in 1 ml of VAN antibiotic cocktail (Vancomycin, Sigma)
100 mg/ml, Amphotericin B (Sigma) 50 mg/ml, Naladixic acid
(Sigma) 100 mg/ml). For culture of Map, 0.5 ml of this cell
suspension was then inoculated into Middlebrook 7H12 media sheep challenged with three doses of Telford 9.2 Map strain.
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that had been supplemented with 0.1 ml PANTA Plus, 5 mg
mycobactin J, and 0.8 ml of egg yolk, and the samples were
incubated for 60 days at 37 C in a monitored incubator (BACTEC
460; Johnston Laboratories, Towson, MD, USA) and the growth
index was determined weekly.
In case of tissue samples, approximately 1 g of tissue was
homogenized in 20 ml of sterile water in a Stomacher (Colworth;
Seaward, Norfolk, United Kingdom). The tissue homogenate was
ﬁltered through sterile cheesecloth and decontaminated with an
equal volume of 0.75% CPC for 40 min. The decontaminated tissue
homogenate was centrifuged at 3500  g for 20 min. The pellet was
re-suspended in 1 ml of sterile water, and 0.5 ml was inoculated
into 5 ml of Middlebrook 7H9 medium that was supplemented
with oleic albumin dextrose catalase (OADC) growth supplement,
egg yolk (0.8 ml), 5 mg mycobactin J and 0.1 ml PANTA Plus, and the
samples were incubated for 60 days at 37 C in a monitored
incubator, BACTEC 460. Mycobactin-dependent growth index
positive samples (faecal as well as tissue) were conﬁrmed by ZN
staining.
Map isolates from challenge inoculum (Telford 9.2) and 6 post-
challenge samples (4 faecal and two tissue) were strain-typed by
VNTR/SSR analysis as described in Subharat et al. (2012). Map
culture was set up using the BACTEC system as described above and
DNA extracted from Map cultures using the modiﬁed QIAamp DNA
stool kit (Qiagen Pty Ltd., Doncaster, Victoria, Australia) as per
protocol described (Subharat et al., 2012). PCR analysis was carried
out at ﬁve variable number tandem repeat (VNTR) loci (292, 25,
Chi3, 7 and 3) and a short sequence repeat (SSR8) locus that were
previously shown to provide optimum resolution of NZ Map
subtypes (Collins et al., 2011).
2.7. Statistical analyses
All continuous variables (bodyweights and IFN-g responses)
were analysed using PROC MIXED procedure in SAS9.4 (SAS
Institute Inc., Cary NC, USA), to test the signiﬁcance of differences
between different time-points. In case of IFN-g responses, the
corrected OD450 readings (OD450 + 0.00001) were log-transformed
to normalise data. The linear mixed model (Littell et al., 1998)
included the ﬁxed effects of time (different time-points) andFig. 3. IFN-g responses to puriﬁed protein derivative of Mycobacterium avium overrandom effects of animals. An auto-regressive model of ﬁrst order
(AR 1) was found to be the most appropriate error structure for
repeated measures, based on AIC values. Resulting least square
means (LSM) along with standard errors (SE) were used to plot the
graphs (Figs. 2 and 3). Antibody responses as well as isolation of
Map in faeces, were treated as dichotomous variables (positive and
negative) and were expressed as percent sheep positive at different
time-points (Figs. 4 and 5). Mean  SE were estimated for graded
histopatholgical variables pertaining to the tissue samples
collected at necropsy. Finally, the prevalence of Map in tissues
sampled at necropsy was expressed as % sheep positive.
3. Results
3.1. Animal losses
Of the 56 Map challenged sheep, 33 survived until the end of the
trial (63 weeks post-C1). Ten animals either died or were humanely
euthanised for reasons unrelated to the Map infection (two due to
dog attack at 16 weeks, four due to post-shearing hypothermia at
42 weeks and one each owing to coccidiosis at 24 weeks, intestinal
intussusception at 23 weeks, mesenteric volvulus at 25 weeks and
facial eczema at 59 weeks), during the course of the trial. Thirteen
sheep were euthanised between weeks 32 and 58 post-C1 due to
progressive weight loss and/or deterioration in body condition, a
typical sign of clinical JD.
3.2. Body weights
The mean body weight (Fig. 2) was 19.65  0.33 kg on the day of
C1 and it increased to 47.21 1.24 kg at 62 weeks post-PC1, with an
overall growth rate of 62.21 g/day. The stress effect of challenge
(during the ﬁrst 4 week period) on growth rate was evident from the
fact that the average daily gain (ADG) in body weight prior to
challenge (72.7 g/day) dropped to just 19.2 g/day during this time.
Maximum ADG was evident during weeks 4 to 8 weeks post-
challenge and it was lowest between weeks 45 and 54 post-
challenge. Seventeen animals (30.4% of the challenged) exhibited
progressive weight loss (>10% in successive 4-week periods) during
the course of the trial and 13 were euthanised as stated above. The
remaining 4 animals were euthanised at the end of the trial. time in Merino sheep challenged with three doses of Telford 9.2 Map strain.
Fig. 4. Antibody responses (depicted as per cent animals positive) to Map over time in Merino sheep challenged with three doses of Telford 9.2 Map strain.
Fig. 5. Photomicrographs of granulomas in sections from mesenteric lymph node (MLN) and liver, and AFB in a section of ileo-caecal valve, in Merino sheep challenged with
the Telford 9.2 Map strain. MLN with a grade 5 lesion, >60% granuloma (A), MLN with a grade 2 lesion, 5–20% granuloma (B) (H&E stain, magniﬁcation 200); liver with a grade
5 lesion, 10 granulomas/ﬁeld (C) (H&E stain, 40 magniﬁcation) and AFB in ileo-caecal valve grade 5, large number of red-stained organisms present in lesions (D) (ZN stain,
magniﬁcation 1000). Arrow indicated granuloma.
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A rapid increase in whole blood IFN-g responses to PPDA (mean
OD450 of 1.32  0.01) was evident (Fig. 3) as early as 8 weeks post-
C1. IFN-g responses peaked at 33 weeks post-C1 (mean corrected
OD450 of 1.70  0.15) and levels were still signiﬁcantly high at 54
weeks post-C1 (mean OD450 of 1.10  0.11). Approximately 36% of
the sheep were positive for Map antibodies in the serum as early as
8 weeks post-C1 (Fig. 4). Approximately 55% of animals gave apositive antibody response at 16 weeks post-C1and 41–51% tested
positive during 32–62 weeks post-C1. Of the 33 sheep that survived
until the end of the trial, 8 animals tested negative at all the time-
points post-C1.
3.4. Histopathology
Typical granulomatous lesions were observed in the intestinal
tissues (ICV and MLN) examined in the study, while the
Fig. 6. Faecal cultures: percent sheep positive for Map over time in Merino sheep
challenged with three doses of Telford 9.2 Map strain.
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lence of microscopic lesions as well as AFB in the three tissue
samples (ICV, MLN and liver) collected from the 33 sheep that
survived until the end of the trial are presented in Table 1. There
was no signiﬁcant difference between the three tissues with regard
to the per cent sheep positive for granulomatous lesions (range:
48.5–59.4%). However, a signiﬁcantly (P < 0.05) lower proportion
of sheep (9.1%) exhibited AFB in liver, compared with those in ICV
(42.4%) and MLN (40.6%). In tissues with identiﬁed lesions, the
mean degree of granulomatous inﬁltration in ICV, MLN and liver
were 2.84  0.43, 2.42  0.32 and 3.31 0.39 respectively. All 13
animals euthanised during the course of the trial for progressive
body weight loss had histopathological lesions and AFB that were
pathognomonic for Johne’s disease.
3.5. Map culture and strain typing of Map
The prevalence of faecal shedding of Map at week 0 and
subsequent 4 weekly intervals from weeks 36 to 62 post-C1 are
presented in Fig. 6. All of the sheep tested negative for Map in pre-
challenge faecal samples. Approximately 92% of sheep tested
positive for Map in faeces at 36 weeks post- C1 and the prevalence
decreased gradually over time. In terms of persistency of faecal
shedding of Map by the 33 surviving animals, 9 of the 33 surviving
sheep were positive for all of the seven time-points tested post-C1,
thus demonstrating a persistent infection, while 2 were negative
throughout. Four animals tested positive on only one occasion and
the remainder were intermittent shedders. Of the 13 sheep that
were euthanised during the course of the trial, 10 animals excreted
Map in their faeces at all tested time-points.
Data on prevalence of Map in tissue cultures from the 33 sheep
that survived until the end of the trial are shown in Table 2. A
signiﬁcantly lower number of sheep (15.2%) tested positive for Map
in liver, compared to those in case of ICV (84.8%) and MLN (66.7%).
Twenty eight out of 33 sheep tested positive for Map in at least one
of the three tissues.
Strain-typing of Map isolates from challenge inoculum (Telford
9.2) and randomly chosen faecal (4) and tissue (2) samples,
employing 5 VNTR and one SSR markers that had been previously
shown to optimally distinguish NZ Map types (Verdugo et al.,
2014)), revealed that the VNTR/SSR type of all the isolates matched
that of the most common sheep type.
4. Discussion
Three doses of cultured Telford 9.2 Map strain from a ﬁeld
isolate in NSW, Australia was shown to result in classical signs of
JD, similar to natural infection, in Australian Merinos (Begg et al.,
2010). In the study reported here, NZ Merinos, reared under NorthTable 1
Histopathology results in surviving Merino sheep euthasised at 63 weeks post-challen
ICVc
No. of sheep +ve for AFBc 14 
% sheep +ve for AFB 42.4 
Mean degree of AFB prevalencea in lesion +ive sheep 2.80  0.48 
No. of sheep +ve for lesions 19 
% sheep +ve for lesions 57.6 
Mean degree of granulomatous inﬁltrationb in lesion +ive sheep 2.84  0.43 
a Sections of ICV and MLN were subjectively graded (on a 0–5 scale) based on% inﬁl
macrophages forming typical mycobacterial granulomas. The liver sections were graded (
3 = 2–4; 4 = 5–9%; 5 = 10 or more) per 4 ﬁeld.
b AFB per 4 ﬁeld of microscopic lesions in each tissue and in each individual were su
1 = single organism; 2 = organisms uncommon; 3 = small number of organisms in some
present in lesions).
c ICV = ileo-caecal valve; MLN = mesenteric lymph node; AFB = acid fast bacilli; N/A = Island of NZ environmental conditions, were challenged with the
same source of Map. Fifty six four-month old lambs were
challenged with three doses of Map and the animals were
monitored for 63 weeks post-challenge.
Approximately 30% of the challenged sheep exhibited progres-
sive weight loss during the trial resulting in 13 animals being
euthanised between weeks 32 and 58 post-C1. These animals also
exhibited histopathological lesions characteristic of JD. This loss of
nearly 23% of the animals within 12 months post-challenge was
unexpected. Begg et al. (2010) reported that when a similar dose of
the pure culture seed-stock was administered to Australian
Merinos there was no evidence of weight loss during the ﬁrst
12 months post-challenge and only 17% of the challenged sheep
showed progressive weight loss at the conclusion of trial (13
months post-challenge). Also, in a different study (Begg et al.,
2005) undertaken in the South Island of New Zealand using NZ
Merino sheep challenged with three doses of infected tissue
homogenate (containing 5 108 CFU of Map per dose) weight loss
was observed only after 11 months post-challenge. A further trial
in the same study found no weight loss in any of the 30 challenged
lambs during the study period (10 months post-challenge). In the
current study, in addition to the 13 animals that were euthanised
during weeks 32 and 58, 4 sheep showed evidence of progressive
weight loss towards the end of the trial (63 weeks post-C1).
Except for the sudden steep drop in ADG during the ﬁrst 4
weeks post-C1 (a possible indication of the stress related to the
three challenge doses of Map), the overall trend in growth rate
(Fig. 2) was broadly typical of that expected due to seasonalge with three doses of Telford 9.2 Map strain.
MLNc Liver In at least one tissue In all three tissues
13 3 14 3
40.6 9.1 42.4 9.1
1.21  0.25 0.16  0.09 N/A N/A
19 16 19 16
59.4 48.5 57.6 48.5
2.42  0.32 3.31  0.39 N/A N/A
tration (0 = no inﬁltration; 1 = <5%; 2 = 5–20%; 3 = 21–40%; 4 = 41–60%; 5 = >60%) of
on a 0–5 scale) based on the number of granulomas (0 = no granuloma; 1 = <1; 2 = 1;
bjectively graded on a scale of 0–5, based on the number of organisms (0 = no AFB;
 macrophages; 4 = moderate organisms in lesions; 5 = large number of organisms
not applicable.
Table 2
Tissue culture results in surviving Merino sheep euthasised at 63 weeks post-challenge with three doses of Telford 9.2 Map strain.
ICVa MLNa Liver In at least one tissue In all three tissues
No. of sheep +ve for Map 28 22 5 28 5
% sheep +ve for Map 84.8 66.7 15.2 84.8 15.2
a ICV = ileo-caecal valve; MLN = mesenteric lymph node.
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grass. The mean body weight of the sheep was continuing in an
upward trend at the end of the trial. However, high variation
(indicated by SE) in ADG (Fig. 2) from around 26 weeks post-C1
onwards is a reﬂection of progressive weight loss exhibited by a
few individuals during that period.
Several studies have investigated the kinetics of IFN-g and
antibody production in sheep experimentally infected with Map. A
surge in IFN-g production, concomitant with infection status is
generally evident (Gwozdz et al., 2000; Gwozdz and Thompson,
2002; Reddacliff and Whittington, 2003; Stewart et al., 2004; Begg
et al., 2005, 2010). This surge occurs 2–4 months post-infection
(coinciding with the early onset of transient faecal shedding of
Map) and typically declines around the time when clinical signs of
JD become apparent and antibody responses increase. In the
current study, whole blood IFN-g responses were high throughout
the period 8 to 54 weeks post-C1 (Fig. 3). This is consistent with
removal of clinical cases and the ﬁndings of the study in Australian
Merinos (Begg et al., 2010), where >80% of the animals tested
positive for IFN-g responses between 4 and 13 months post-
challenge. Similar high responses during 3 to 15 months post-
challenge were also evident in calves (Subharat et al., 2012), while
in goats experimentally infected with a bovine strain of Map, IFN-g
responses remained elevated for up to 12–16 months following the
commencement of persistent faecal shedding (Stewart et al.,
2006). Also, in a different experimental infection study in goats
(Storset et al., 2001) detectable IFN-g responses were seen from 9
weeks post-challenge through to 2 years of study.
The antibody response that we report in the current study is
unprecedented. More than one third of the sheep were sero-
positive for antibodies to Map by as early as 8 weeks post-C1 and
between 41 and 55% of the animals were positive during the study
period (Fig. 4). This very early onset antibody response is
surprising considering the reported delayed onset in other sheep
Map challenge studies. No antibody responses could be detected in
Australian Merinos (Begg et al., 2010) by 4 months post-challenge
with only 10% of the sheep testing positive by 8 months. Antibody
levels in NZ Merinos (Begg et al., 2005), exposed orally to medium
or high doses of tissue homogenates of Map remained at
background levels until at least 6 to 9 months and peaked at 9
months post-challenge (just before clinical disease was evident). In
a different challenge study (Stewart et al., 2004) involving
Australian Merinos, none of the clinically affected sheep developed
antibody responses, despite the presence of persistent faecal
shedding of Map. Compared with sheep, goats were found to
evince early and strong serum antibody responses (Storset et al.,
2001; Munjal et al., 2005; Stewart et al., 2006). Antibody responses
in experimentally infected cattle are not usually detected until 10–
17 months post-infection (Lepper et al., 1989). The reason for the
rapid (8 weeks post-challenge) antibody response in our study is
unknown, but may reﬂect the susceptibility of the sheep, the
severity of the challenge and/or the environmental conditions.
Consistent with the high prevalence of antibody and interferon
gamma response, was the ﬁnding that approximately 92% of the
sheep were faecal culture positive for Map at 36 weeks post-C1, the
earliest time-point of faecal culturing post-challenge (Fig. 6). This
high prevalence of faecal shedding of Map is quite different to thatseen in the Australian study (Begg et al., 2010), where just over 20
and 44% sheep were positive at 8 and 13 months post-challenge,
respectively. In the current study, the prevalence of shedding
gradually decreased over time, with nearly 39% of the animals
being culture positive at 62 weeks post-C1. This decrease could
partly be attributed to culling of sheep exhibiting clinical signs
during weeks 32 and 58, post-C1. Persistent faecal shedding,
during 2–9 months post-infection, was also reported in a high
proportion of goats challenged with a bovine Map strain (Stewart
et al., 2006). Similarly, a meta-analysis of 17 studies that looked at
faecal shedding of Map in experimentally infected calves (Mitchell
et al., 2012) revealed two peaks (3 and 36 months) of shedding
post-infection. Faecal shedding of Map usually precedes the onset
of serum antibody responses (Whittington et al., 2001; Stewart
et al., 2006). Hence, considering the very early onset of antibody
responses in the infected lambs of the current study, it would have
been interesting to examine faecal shedding during the early post-
infection period, but restrictions on the availability of culturing
facilities precluded these samples from being tested.
Strain-typing of Map (Subharat et al., 2012) from the challenge
inoculum as well as randomly chosen faecal and tissue samples
indicated that all the isolates had the same VNTR/SSR genotype.
Also, whole genome sequencing of the Map isolates from 9 selected
faecal and tissue samples indicated that they were identical to the
challenge strain (data not shown).
Examination of post mortem tissue at the end of the trial
showed that 58% of sheep exhibited histo-pathological lesions in at
least one of the three tissues sampled (ICV, MLN and liver), while
42% of the animals were positive for AFB in at least one tissue
(Table 1). In the Australian study (Begg et al., 2010) a relatively a
higher proportion (72%) of challenge sheep had histo-pathological
lesions. The difference in the two studies may be due in part to the
rapid onset of disease in some of the NZ animals that were then
culled prior to the end of the trial. The observed high proportion of
sheep (85%, Table 2) positive for Map in at least one of the three
tissues cultured, was inconsistent with the histopathological
ﬁndings and is probably a reﬂection of the higher sensitivity of
the culturing technique. A high proportion of animals exhibiting
microscopic lesions (75–80%) and Map in tissue cultures (80–100%)
at necropsy was also evident in cattle (Subharat et al., 2012) and
goat (Kathaperumal et al., 2009) challenge studies.
The dose of cultured Map strain Telford 9.2 used in the current
study resulted in more severe infection in NZ Merino sheep
compared to those seen in the Australian study, where a similar
dose was found to give immune responses and clinical signs similar
to natural JD. The reasons for this difference are speculative but
could be due to several factors including the inherent breed
differences between the Australian and NZ Merinos. Another
important factor could be a genotype-environment interaction. In
NZ, Merinos are better suited to the relatively drier and hilly
regions of the South Island compared to the wetter low-land found
in the Manawatu region of the North Island and this may have
resulted in additional stress for the sheep.
In conclusion, cultured Telford 9.2 Map strain was highly
effective at establishing JD in NZ Merino lambs. However, the rapid
onset of immune responses and clinical signs of disease in some
animals and the high percentage of sheep that were positive for
V.S.R. Dukkipati et al. / Veterinary Microbiology 195 (2016) 136–143 143Map in the faeces were more intense outcomes than seen in
Australia, and those usually seen following natural exposure to the
organism. Taken together these ﬁndings suggest that the
susceptibility of ruminants to clinical JD may be inﬂuenced by
environmental factors. Thus, titration of the challenge dose is
particularly important when designing trials in new environments
or with genetic lines of sheep not previously investigated.
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